| NDC Code | 69097-805-40 |
|---|
| Package Description | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (69097-805-40) |
|---|
| Product NDC | 69097-805 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Azacitidine For |
|---|
| Non-Proprietary Name | Azacitidine |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS; SUBCUTANEOUS |
|---|
| Start Marketing Date | 20190326 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA207518 |
|---|
| Manufacturer | Cipla USA Inc. |
|---|
| Substance Name | AZACITIDINE |
|---|
| Strength | 100 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC] |
|---|